Abstract
For cancer survivors, social parenthood buffers distress and improves quality of life. It is important that physicians dealing with treatment of malignancies are aware of this patient perspective. This review deals with risks of infertility with hematological malignancies and chemotherapy, modes of fertility preservation interventions, time and barriers to referral to specialists offering these interventions. This review aims to guide the hemato-oncologist to make an informed decision with the patient and the partner about fertility preservation at the right time.
Similar content being viewed by others
References
Canada AL, Schover LR (2012) The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology 21(2):134–143
Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18):2917–2931
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(19):2500–2510
Quinn GP, Vadaparampil ST, Bell-Ellison BA, Gwede CK, Albrecht TL (2008) Patient-physician communication barriers regarding fertility preservation among newly diagnosed cancer patients. Soc Sci Med 66(3):784–789
Brougham MF, Wallace WH (2005) Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol 131(2):143–155
Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF et al (1992) Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166(3):788–793
Chatterjee R, Kottaridis PD (2002) Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies. Bone Marrow Transplant 30(10):629–635
Chemes HE (2001) Infancy is not a quiescent period of testicular development. Int J Androl 24(1):2–7
Thomson AB, Campbell AJ, Irvine DC, Anderson RA, Kelnar CJ, Wallace WH (2002) Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 360(9330):361–367
Green DM, Liu W, Kutteh WH, Ke RW, Shelton KC, Sklar CA et al (2014) Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol. 15(11):1215–1223
Agarwal A, Shekarriz M, Sidhu RK, Thomas AJ Jr (1996) Value of clinical diagnosis in predicting the quality of cryopreserved sperm from cancer patients. J Urol 155(3):934–938
Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O et al (2001) Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol 12(9):1307–1311
Hallak J, Mahran A, Chae J, Agarwal A (2000) The effects of cryopreservation on semen from men with sarcoma or carcinoma. J Assist Reprod Genet 17(4):218–221
Trottmann M, Becker AJ, Stadler T, Straub J, Soljanik I, Schlenker B et al (2007) Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur Urol 52(2):355–367
Pal L, Leykin L, Schifren JL, Isaacson KB, Chang YC, Nikruil N et al (1998) Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod 13(7):1837–1840
Nakayama K, Milbourne A, Schover LR, Champlin RE, Ueno NT (2008) Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers. Nat Clin Pract Oncol 5(2):78–89
Chatterjee R, Haines GA, Perera DM, Goldstone A, Morris ID (2000) Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum Reprod 15(4):762–766
Leader A, Lishner M, Michaeli J, Revel A (2011) Fertility considerations and preservation in haemato-oncology patients undergoing treatment. Br J Haematol 153(3):291–308
Loren AW (2015) Fertility issues in patients with hematologic malignancies. Hematol Am Soc Hematol Educ Program 2015:138–145
Leiper AD, Stanhope R, Lau T, Grant DB, Blacklock H, Chessells JM et al (1987) The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 67(4):419–426
Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML (1989) Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) 31(3):363–373
Meistrich ML (2009) Male gonadal toxicity. Pediatr Blood Cancer 53(2):261–266
Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18(1):117–121
Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P et al (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358(9278):271–276
Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7):3045–3052
Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS et al (2006) Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 37(11):1023–1029
Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S et al (2011) Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 17(2):157–166
Mahajan N (2015) Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci 8(1):3–13
Medicine PCoASfR (2013) Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 100(5):1214–1223
National Institute for Health and Clinical Excellence (2013) Fertility: assessment and treatment for people with fertility problems (update). (Clinical guideline 156). www.nice.org.uk/CG156
Revel A, Revel-Vilk S (2008) Pediatric fertility preservation: is it time to offer testicular tissue cryopreservation? Mol Cell Endocrinol 282(1–2):143–149
Alvarez RM, Ramanathan P (2016) Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response. Hum Reprod. doi:10.1093/humrep/dew158
Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H et al (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23(5):1007–1013
Meistrich ML, Shetty G (2008) Hormonal suppression for fertility preservation in males and females. Reproduction 136(6):691–701
Chen H, Li J, Cui T, Hu L (2011) Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev (11):CD008018. doi:10.1002/14651858.CD008018.pub2
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no potential conflicts of interest to disclose.
Ethical Approval
This article does not contain any studies with human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Karunakaran, P., Malhotra, P. & Lad, D. Fertility Management for the Hemato-Oncologist. Indian J Hematol Blood Transfus 34, 13–18 (2018). https://doi.org/10.1007/s12288-017-0887-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-017-0887-8